Yeo‐Kyeoung Kim

Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

Tae‐Hyung Kim, Marc S. Tyndel, Hyeoung Joon Kim et al. · Blood · 2016 · 139 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse

Tae‐Hyung Kim, Joon Ho Moon, Jae-Sook Ahn et al. · Blood · 2018 · 110 citations · Full text

Medicine, Hematology, Oncology +15

Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma

Deok‐Hwan Yang, Jung‐Joon Min, Ho‐Chun Song et al. · European Journal of Cancer · 2011 · 88 citations

Medicine, Oncology, Chemotherapy +8

The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma

Deok‐Hwan Yang, Jungsun Park, Chun-Ji Jin et al. · Leukemia Research · 2008 · 64 citations

Life Sciences, Immunology, Oncology +16

Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists

Thanh-Nhan Nguyen-Pham, Mi-Seon Lim, Truc Anh Thi Nguyen et al. · Cellular and Molecular Immunology · 2011 · 51 citations · Full text

Life Sciences, Immunology, Molecular Biology +12